Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 30(2): 344, 2019 02 01.
Article
en En
| MEDLINE
| ID: mdl-29741569
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Ann Oncol
Asunto de la revista:
NEOPLASIAS
Año:
2019
Tipo del documento:
Article